- Price is above Fair Value, showing premium demand versus the model.
UZU
GER
Week ended 07 Aug 2026
Weekly Investor Report
Uzin Utz SE · Basic Materials · Specialty Chemicals
Latest close
59.40 EUR
-2.3%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -12.0% below the Trend Line and sits at 20.1% of its 52-week range. The latest completed week returned -2.3%, after a -6.0% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is inexpensive relative to peers. The latest news-sentiment score is 55/100. Near-term considerations: volume confirmation is below normal.
Setup score
27
out of 100
Latest Close
59.40 EUR
7 Aug 2026
1W Return
-2.3%
latest completed week
4W Return
-6.0%
short-term follow-through
12W Return
-14.4%
quarterly tape
Trend Breadth
61.5%
32 of 52 weeks active
Volume Ratio
0.9x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Activity pressure is negative, which weakens the current setup.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-2.3%
Latest completed week; four-week move -6.0%.
Indicator stack
34/43
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
55/100
3 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -12.0% below the Trend Line and sits at 20.1% of its 52-week range. The latest completed week returned -2.3%, after a -6.0% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0412-week average 0.13
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.04Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -6.0% over four weeks, -14.4% over 12 weeks, and -8.2% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year32
Trend breadth61.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.54Latest activity-pressure read.
Pressure change28.7%Four-week change in activity pressure.
Leadership-20.18Latest relative-leadership reading.
RS change-77.2%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is inexpensive relative to peers.
Factor week 09 Aug 2026
Financial statements through 31 Dec 2025
Field coverage 91%
Model confidence 72%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength76/100Blend of value, momentum, and quality. Underlying universe rank 25; rank 1 is best.
Value89/100Relative valuation strength. Underlying universe rank 12; rank 1 is best.
Quality37/100Profitability and accounting quality. Underlying universe rank 64; rank 1 is best.
Momentum29/100Medium-term price momentum. Underlying universe rank 72; rank 1 is best.
Growth34/100Revenue and earnings growth. Underlying universe rank 67; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework75/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 11.3x Price divided by trailing earnings.
- Price / sales
- 0.6x Market value relative to trailing revenue.
- EV / EBITDA
- 5.4x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 3.8% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 59.1% Gross profit retained from each unit of revenue.
- Operating margin
- 7.9% Operating profit retained from revenue.
- Free-cash-flow margin
- 2.5% Free cash flow generated from revenue.
- Return on invested capital
- 9.1% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 6.1% Latest one-year revenue growth.
- EPS growth
- -10.2% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- -66.8% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 7/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 3.2% Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 3.2% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 0.6x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment55/100
Weighted news tone is neutral across 3 relevant articles.
1 positive · 2 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-30.6%Distance below the 52-week high.
13-week volatility8.3%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher7 of 2616 weeks finished lower.
Best week+24.5%Week of 19 Jun.
Worst week-8.4%Week of 26 Jun.
Latest week-2.3%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains3
Flat weeks3
Modest losses7
Sharp losses9
Recent vol8.3%13-week weekly-return volatility.
Base vol5.2%52-week weekly-return volatility.
Up/down split18/26Count of positive and negative weeks in the 52-week window.
Average skew4.9% / -3.5%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorDE Basic Materials
4-week rank40 / 44
Group average3.5%
Trend breadth47.7%
Trend47.7%active weekly trend signals
MD20.5%positive activity pressure
RS50.0%positive relative leadership
Four-week leaders
IndustryDE Specialty Chemicals
4-week rank15 / 18
Group average1.0%
Trend breadth61.1%
Trend61.1%active weekly trend signals
MD44.4%positive activity pressure
RS50.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape28/100
Trend, activity pressure, participation, and risk combine to a 28/100 tape read.
Indicator analysis9/100Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.
Activity pressure 0.04; No reversal markers Factors58/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 83; Small Cap Core rank 18 SVQF75/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 95.5 of 375 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment55/100Weighted news tone is neutral across 3 relevant articles.
Uzin Utz SE Revenue Breakdown – XETR:UZU Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 59.40 EUR | -2.3% | 67.49 EUR | 54.63 EUR | -0.54 | -20.18 | 1.8K | Off |
| 31 Jul 2026 | 60.80 EUR | 0.7% | 67.87 EUR | 54.53 EUR | -0.58 | -16.34 | 987 | Off |
| 24 Jul 2026 | 60.40 EUR | 0.0% | 68.15 EUR | 54.43 EUR | -0.63 | -15.31 | 1.2K | Off |
| 17 Jul 2026 | 60.40 EUR | -4.4% | 68.46 EUR | 54.34 EUR | -0.76 | -14.51 | 1.0K | Off |
| 10 Jul 2026 | 63.20 EUR | -2.5% | 68.73 EUR | 54.25 EUR | -0.76 | -11.39 | 1.1K | Off |
| 3 Jul 2026 | 64.80 EUR | 5.5% | 68.88 EUR | 54.13 EUR | -1.08 | -11.63 | 10 | Off |
| 26 Jun 2026 | 61.40 EUR | -8.4% | 69.00 EUR | 54.01 EUR | -1.32 | -12.58 | 309 | Off |
| 19 Jun 2026 | 67.00 EUR | 24.5% | 69.15 EUR | 53.93 EUR | -1.42 | -5.78 | 802 | Off |
| 12 Jun 2026 | 53.80 EUR | -5.3% | 69.25 EUR | 53.79 EUR | -1.46 | -23.16 | 273 | Off |
| 5 Jun 2026 | 56.80 EUR | -5.6% | 69.84 EUR | 53.76 EUR | -1.28 | -19.48 | 1.7K | Off |
| 29 May 2026 | 60.20 EUR | -5.9% | 70.31 EUR | 53.68 EUR | -1.01 | -15.92 | 2.5K | Off |
| 22 May 2026 | 64.00 EUR | -7.8% | 70.69 EUR | 53.61 EUR | -0.88 | -9.81 | 13.6K | Off |
| 15 May 2026 | 69.40 EUR | 2.5% | 70.94 EUR | 53.50 EUR | -0.81 | 1.68 | 781 | Off |
| 8 May 2026 | 67.73 EUR | -2.0% | 71.01 EUR | 53.36 EUR | -0.81 | -2.11 | 3.0K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.